Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000403

Drug Information
NameSpectinomycin    
SynonymsAC1L21W5; BPBio1_000735; Spectinomicina; 1695-77-8 (Parent); CHEMBL1167; LS-127328; Prestwick0_000804; EINECS 216-911-3; Spectrum5_001407; KBioGR_001425; KBio1_000137; CID15541; MolPort-004-947-049; Spectam; UNII-93AKI1U6QF; STOCK1N-24271; 1695-77-8; Spectrum3_000898; MLS001032090; M 141; XK 43-1; Prospec (TN); NSC 132679; 4H-Pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, (2R-(2alpha,4abeta,5abeta,6beta,7beta,8beta,9alpha,9aalpha,10abeta))-; KBio3_001816; 4H-Pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-; Antibiotic 2233wp; SMP1_000276; 21736-83-4 (di-hydrochloride, anhydrous); SPBio_001409; MolPort-002-513-665; Prestwick2_000804; NSC248616; HMS2089C03; Actinospectacina [Italian]; (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)decahydro-4H-pyrano[2,3-b][1,4]benzodioxin-4-one; BSPBio_000667; Actinospectacina; 21736-83-4; M-141; Spectrum4_000993; ACTINOSPECTACIN, ESPECTINOMICINA, CHX-3101; Trobicin; Spectinomycin Hydrochloride (anhydrous); KBio2_004002; Spectinomycin sulfate; Spectinomycine; 4H-Pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-; Spectinomycin HCl; Stanilo; AC1L21VZ; AC-13570; SPBio_002588; CID64771; AC1MHWL1; Spectrum2_001315; NCGC00142531-02; U 18409; 4H-Pyrano[2,3-b][1,4]benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-; 4H-Pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, monohydrochloride, (2R-(2alpha,4abeta,5abeta,6beta,7beta,8beta,9alpha,9aalpha,10abeta))-; Spectinomycin hydrochloride anhydrous; Espectinomicina; Spectam Scour Halt; CHEBI:45551; Spectinomicina [Italian]; Spectinomycin (INN); U-18409AE; Spectinomycinum; Spectinomycinum [INN-Latin]; Adspec (TN); Togamycin; Spectinomycin [INN:BAN]; Togamycin sulfate (1:1); Espectinomicina [INN-Spanish]; IDI1_000137; (2R-(2alpha,4abeta,5abeta,6beta,7beta,8beta,9alpha,9aalpha,10abeta))-Decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-4H-pyrano(2,3-b)(1,4)benzodioxin-4-one monohydrochloride; Spectinomycin monohydrochloride; 4H-Pyrano[2,3-b][1,4]benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, [2R-(2.alpha.,4a.beta.,5a.beta.,6.beta.,7.beta.,8.beta.,9.alpha.,9a.alpha.,10a.beta.)]-, sulfate (1:1) (salt); actinospectacin; Spectinomycin dihydrochloride; NCGC00180937-01; Spectinomycin Di HCl; AC1L263X; 23312-56-3; AC1Q3EJ7; NCI60_000023; KBioSS_001434; 4H-Pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, (2R-(2-alpha,4a-beta,5a-beta,6-beta,7-beta,8-beta,9-alpha,9a-alpha,10a-beta))-; DivK1c_000137; 22189-32-8 (di-hydrochloride, pentahydrate); Prospec; EINECS 245-578-7; Spectinomycin; 22189-32-8; CID64769; DB00919; D08526; U 18409 E; NINDS_000137; BRN 2171701; CID3033928; CHEMBL1200407; SCM; SPCM; KBio2_001434; KBio2_006570; NCGC00142531-01; NSC132679; C02078; NSC100859; Prestwick3_000804; Spectinomycin Dihydrochloride, Anhydrous; Spectinomycin HCl/ Sulphate; C14H24N2O7; Spectrum_000954; Spectogard; Spectinomycin Dihydrochloride, Pentahydrate; EINECS 244-554-3; C14H24N2O7.2HCl; Spectinomycin hydrochloride; Actinospectacin, hydrochloride; AC1Q6CAT; LS-127327; Prestwick1_000804; NSC 248616; ST057253; 22193-75-5; Adspec; Spectinomycine [INN-French]    
Trade NameTrobicin    
CompanyPharmacia & Upjohn Company    
IndicationBacterial infectionsApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntibacterial Agents    
CAS NumberCAS 1695-77-8
FormularC14H24N2O7    
PubChem Compound IDCID 64771.    
PubChem Substance IDSID 206715.    
SuperDrug ATC IDJ01XX04;    
SuperDrug CAS ID001695778;    
Target30S ribosomal subunitBinder[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 050347 To Reference
Ref 2Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature. 2000 Sep 21;407(6802):340-8. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543